Assignee

RISEN SUZHOU PHARMA TECH CO LTD

CN·18 granted patents·19 pending applications·22 citations·filing 2017–2025

Technology mixA61P37 A61K27 C07B22 C07D22 C07C16 C07H15

Top patents by PatentIndex Score

37 records

0192US11970490B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Apr 30, 2024·4 cites·24 claims
0290US2026035342A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
0389US11608314B2Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Mar 21, 2023·2 cites·16 claims
0489US11225497B2Prodrugs of a CDK inhibitor for treating cancersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Jan 18, 2022·2 cites·16 claims
0589US10954188B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Mar 23, 2021·4 cites·17 claims
0685US12459888B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2024·Granted Nov 4, 2025·0 cites·3 claims
0785US10472323B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2017·Granted Nov 12, 2019·5 cites·20 claims
0884US11186543B2Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Nov 30, 2021·2 cites·24 claims
0984US2025353870A1Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
1082US11530234B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Dec 20, 2022·1 cites·21 claims
1181US12595260B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Granted Apr 7, 2026·0 cites·6 claims
1279US12312378B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Granted May 27, 2025·0 cites·20 claims
1377US2023295079A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
1476US12552823B2Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Granted Feb 17, 2026·0 cites·5 claims
1576US10881681B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Jan 5, 2021·2 cites·21 claims
1675US11725020B2Prodrugs of a CDK inhibitor for treating cancersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Aug 15, 2023·0 cites·20 claims
1771US2025352516A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular diseaseRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
1869US2025109100A1Crystalline form of 3- ((l-valyl) amino) -i-propanesulfonic acidRISEN SUZHOU PHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
1969US2021347731A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
2068US12365675B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Jul 22, 2025·0 cites·20 claims
2166US12403129B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular diseaseRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Sep 2, 2025·0 cites·2 claims
2262US11591358B2Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Feb 28, 2023·0 cites·15 claims
2362US2024246963A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
2461US2024050577A1Cdk inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
2561US2024239813A1Kras inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
2659US2024116952A1Kras inhibitor and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
2759US2023019098A1Bivalent compounds, conjugates and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
2859US2023321253A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
2958US2023295213A1Cd73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
3058US2024059712A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
3158US2024279265A1Crystal forms of glucosamine derivative, and preparation method therefor and use thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
3258US2026048131A1Bifunctional compounds and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
3356US2024131001A1Pharmaceutical application of fused ring phenolic compoundsRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
3455US12338205B2Crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acidRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Jun 24, 2025·0 cites·20 claims
3554US2024024346A1Cd73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
3650US2021078970A1Prodrugs of the tyrosine kinase inhibitor for treating cancerRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Application pending·0 cites
3743US11718636B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Aug 8, 2023·0 cites·19 claims

Join the waitlist — get patent alerts

Get an alert when RISEN SUZHOU PHARMA TECH CO LTD files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →